跳至主要内容
临床试验/NL-OMON56807
NL-OMON56807尚未招募2 期

Oral Fecal Microbiota Transplantation Capsules from Healthy Donors in Patients with Locally Advanced, Resectable Gastric or Gastro-esophageal Junction Adenocarcinoma - CAPGO

Amsterdam UMC0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Resectable adenocarcinoma of the stomach or gastro*esophageal junction;
  • planned start with neo-adjuvant FLOT
  • -Patient is fit for surgery
  • Healthy fecal donors
  • -Lean body mass of 80-90%

排除标准

  • Past (within 5 years) or current history of malignancy other than entry
  • diagnosis interfering with prognosis of gastro-esophageal cancer, not including
  • superficial and adequately treated skin and cervical malignancies.
  • History of a non-malignant disease of the digestive tract, such as celiac
  • disease, chronic diarrhoea (>=3 stools/day for >4 weeks), chronic obstipation
  • (<2 defecations/week for >3 months), Irritable Bowel Syndrome (IBS) (according
  • to Rome IV criteria) or Inflammatory Bowel Disease (IBD).
  • Uncontrolled (bacterial) infections
  • Healthy fecal donors
  • -Use of antibiotics
  • -Infections such as HIV, hepatitis B or C
  • -Smoking or drug use
  • -Parasite infection
  • -Gastro-intestinal diseases such as IBS or IBD

研究者

发起方
Amsterdam UMC

相似试验

Oral Fecal Microbiota Transplantation Capsules from... | 临床试验